Atraumatic splenic rupture in patients with myelodysplastic syndromes: report of a case occurred during treatment with 5-azacitidine and review of the literature

Leuk Res. 2012 Mar;36(3):e52-6. doi: 10.1016/j.leukres.2011.10.031. Epub 2011 Dec 14.

Authors

Fabio Forghieri, Monica Morselli, Giovanna Leonardi, Leonardo Potenza, Goretta Bonacorsi, Valeria Coluccio, Ambra Paolini, Monica Maccaferri, Elisabetta Colaci, Valeria Fantuzzi, Sara Bigliardi, Piera Zaldini, Giovanni Riva, Patrizia Barozzi, Luca Leonardi, Aldo Rossi, Roberto Marasca, Franco Narni, Mario Luppi

PMID: 22172466
DOI: 10.1016/j.leukres.2011.10.031

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't
Review

MeSH terms

Antimetabolites, Antineoplastic / adverse effects*
Azacitidine / adverse effects*
Female
Humans
Middle Aged
Myelodysplastic Syndromes / drug therapy*
Splenic Rupture / chemically induced*
Treatment Outcome

Substances

Antimetabolites, Antineoplastic
Azacitidine